首页> 外文期刊>Cancer Informatics >A miRNA- and mRNA-seq-Based Feature Selection Approach for Kidney Cancer Biomakers
【24h】

A miRNA- and mRNA-seq-Based Feature Selection Approach for Kidney Cancer Biomakers

机译:基于miRNA和mRNA-SEQ的肾癌生物标志物的特征选择方法

获取原文
           

摘要

Microarray data sets have been used for predicting cancer biomarkers. Yet, replication of the prediction has not been fully satisfied. Recently, new data sets called deep sequencing data sets have been generated, with an advantage of less noise in computational analysis. In this study, we analyzed the kidney miRNA and mRNA sequence data sets for predicting cancer markers using 5 different statistical feature selection methods. In the results, we obtained 3 mRNA- and 27 miRNA-based cancer biomarkers to compare with the normal samples. In addition, we clustered the kidney cancer subtypes using a nonnegative matrix factorization method and obtained significant results of survival analysis from the 2 separate groups including miRNA-342 and its target eukaryotic translation initiation factor 5A ( EIF5A ).
机译:微阵列数据集已用于预测癌症生物标志物。然而,预测的复制尚未完全满足。最近,已经生成了名为Deak Sequencing数据集的新数据集,其具有较少的计算分析中的噪声较少。在这项研究中,我们分析了使用5种不同统计特征选择方法预测癌症标记的肾miRNA和mRNA序列数据集。在结果中,我们获得了3 mRNA和27个MiRNA的癌症生物标志物,以与正常样品进行比较。此外,我们使用非负基质分子化方法聚集肾癌亚型,并获得了来自包括miRNA-342的2个单独组及其目标真核翻译引发因子5a(EIF5a)的实力分析的显着结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号